From: The Sertindole Safety Survey: A retrospective analysis under a named patient use programme in Europe
Number of patients (%)* | Age (Years)** | ||
---|---|---|---|
Mean ± SD | Quartiles (Q1 – Q3) | ||
Male | 637 (44.8) | 37.3 ± 13.1 | 27 – 45 |
Female | 786 (55.2) | 43.6 ± 15.0 | 33 – 53 |
Total | 1,423 (100) | 40.9 ± 14.5 | 30 – 49 |